Literature DB >> 62558

Type C oncornavirus isolation studies in systemic lupus erythematosus. I. Attempted detection by isopycnic sedimentation of 3H-uridine-labelled virions.

P E Phillips, R Hargrave, E Stewart, N H Sarkar.   

Abstract

Type C oncornavirus isolation was attempted from cell cultures of tissues from 7 patients with systemic lupus erythematosus. Detection was based on the characteristic sedimentation of 3H-uridine-labelled virions at a density of 1-16 g/ml. Cultures positive by this method were negative by two other criteria for type C viruses: characteristic virions by electron microscopy and the viral enzyme RNA-directed DNA polymerase. The positive results were probably due to cellular damage by prolonged radiolabelling, with release of organelles containing labelled RNA sedimenting at the same density as type C viruses.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 62558      PMCID: PMC1006574          DOI: 10.1136/ard.35.5.422

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  23 in total

1.  Microvesicles and vesicles of multivesicular bodies versus "virus-like" particles.

Authors:  A J Dalton
Journal:  J Natl Cancer Inst       Date:  1975-05       Impact factor: 13.506

2.  C-type viruses in systemic lupus erythematosus.

Authors:  R M Lewis; W Tannenberg; C Smith; R S Schwartz
Journal:  Nature       Date:  1974-11-01       Impact factor: 49.962

3.  Infectious C-type virus isolated from a baboon placenta.

Authors:  R E Benveniste; M M Lieber; D M Livingston; C J Sherr; G J Todaro; S S Kalter
Journal:  Nature       Date:  1974-03-01       Impact factor: 49.962

4.  Adrenal corticosteroids enhance production of type-C virus induced by 5-iodo-2'-deoxyuridine from cultured mouse fibroblasts.

Authors:  M Paran; R C Gallo; L S Richardson; A M Wu
Journal:  Proc Natl Acad Sci U S A       Date:  1973-08       Impact factor: 11.205

5.  Surface structure of mouse mammary tumor virus.

Authors:  N H Sarkar; D H Moore
Journal:  Virology       Date:  1974-09       Impact factor: 3.616

6.  Transmissible mink encephalopathy: studies on the peripheral lymphocyte.

Authors:  R F Marsh; J M Miller; R P Hanson
Journal:  Infect Immun       Date:  1973-03       Impact factor: 3.441

7.  The nucleic acid of the Bryan strain of Rous sarcoma virus: purification of the virus and isolation of the nucleic acid.

Authors:  W S Robinson; A Pitkanen; H Rubin
Journal:  Proc Natl Acad Sci U S A       Date:  1965-07       Impact factor: 11.205

8.  Murine xenotropic type C viruses I. Distribution and further characterization of the virus in NZB mice.

Authors:  J A Levy; P Kazan; O Varnier; H Kleiman
Journal:  J Virol       Date:  1975-10       Impact factor: 5.103

9.  A distinct class of inducible murine type-C viruses that replicates in the rabbit SIRC cell line.

Authors:  R E Benveniste; M M Lieber; G J Todaro
Journal:  Proc Natl Acad Sci U S A       Date:  1974-03       Impact factor: 11.205

10.  The viral envelope glycoprotein of murine leukemia virus and the pathogenesis of immune complex glomerulonephritis of New Zealand mice.

Authors:  T Yoshiki; R C Mellors; M Strand; J T August
Journal:  J Exp Med       Date:  1974-10-01       Impact factor: 14.307

View more
  3 in total

1.  Type C oncornavirus isolation studies in systemic lupus erythematosus. III. Isolation of a putative retravirus by triple cell fusion.

Authors:  P E Phillips; S A Sellers; S L Cotronei
Journal:  Ann Rheum Dis       Date:  1978-06       Impact factor: 19.103

2.  Type C oncornavirus isolation studies in systemic lupus erythematosus. II. Attempted detection by viral RNA-dependent DNA polymerase assay.

Authors:  P E Phillips; R Hargrave-Granda
Journal:  Ann Rheum Dis       Date:  1978-06       Impact factor: 19.103

3.  Viruses and lymphocytes in rheumatoid arthritis. II. Examination of lymphocytes and sera from patients with rheumatoid arthritis for evidence of retrovirus infection.

Authors:  H Hart; J N McCormick; B P Marmion
Journal:  Ann Rheum Dis       Date:  1979-12       Impact factor: 19.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.